Last reviewed · How we verify
NCT01535001
Structured Non-operative Treatment of Knee Osteoarthritis - a Randomized Controlled Trial of Pain, Physical Function and Quality of Life With 12months Follow-up
NA trial testing Neuromuscular training (NEMEX-TJR) in Osteoarthritis of the Knee in 100 participants. Completed in 1 September 2014.
1 September 2014
Quick facts
| Lead sponsor | Northern Orthopaedic Division, Denmark |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 100 |
| Start date | 1 February 2012 |
| Primary completion | 1 September 2014 |
| Estimated completion | 1 September 2014 |
| Sites | 3 locations across Denmark |
Drugs / interventions tested
- Neuromuscular training (NEMEX-TJR)
- Information
- Paracetamol (Paracetamol) — full drug profile →
- Burana — full drug profile →
- Pantoprazole (pantoprazole) — full drug profile →
- Dietary counseling
- Patient education — full drug profile →
- Insoles
Conditions studied
- Osteoarthritis of the Knee — all drugs for Osteoarthritis of the Knee →
Sponsor
Northern Orthopaedic Division, Denmark — full company profile →
Who can join
18 and older, any sex, with Osteoarthritis of the Knee. Patients with the condition only — healthy volunteers not accepted.
What's being measured
Primary outcomes are the specific endpoints the trial is designed to prove or disprove.
-
Change From Baseline in KOOS4 (Knee Injury and Osteoarthritis Outcome Score)
Time frame: Primary: 12months.
The average score for four of the five KOOS subscales, covering pain, symptoms, difficulties in functions of daily living, and quality of life (KOOS4), with scores ranging from 0 (worst) to 100 (best). Between group comparisons of treatment effect (change in KOOS4 from baseline to 1 year follow-up) will be dependent on data distribution. We expect the change to be normally distributed and analysi
Sponsor's own description
The purpose of this study is to test whether an algorithm for systematic non-surgical treatment consisting of corrective insoles, neuromuscular training, weight loss, patient education and pharmacological treatment with paracetamol, non steroidal anti inflammatory drugs (NSAIDs) and Pantoprazole provides further improvement in pain, function and quality of life than standard non-surgical treatment (information on the disease and how to treat it) in patients with knee osteoarthritis. The H1-hypothesis is that the treatment algorithm results in a greater increase in quality of life and functional capacity and greater reduction in pain than standard treatment at the primary endpoint, which is follow-up 12months after the start of the treatment. See statistical analysis plan available under "Links" for further description of the study.
Publications & conference data
7 peer-reviewed publications reference this trial (live from Europe PMC):
-
Total knee replacement and non-surgical treatment of knee osteoarthritis: 2-year outcome from two parallel randomized controlled trials.
Skou ST, Roos EM, Laursen MB, Rathleff MS, et al · · 2018 · cited 123× · PMID 29723634 · DOI 10.1016/j.joca.2018.04.014 -
The efficacy of 12 weeks non-surgical treatment for patients not eligible for total knee replacement: a randomized controlled trial with 1-year follow-up.
Skou ST, Rasmussen S, Laursen MB, Rathleff MS, et al · · 2015 · cited 60× · PMID 25937024 · DOI 10.1016/j.joca.2015.04.021 -
The efficacy of non-surgical treatment on pain and sensitization in patients with knee osteoarthritis: a pre-defined ancillary analysis from a randomized controlled trial.
Skou ST, Roos EM, Simonsen O, Laursen MB, et al · · 2016 · cited 23× · PMID 26241775 · DOI 10.1016/j.joca.2015.07.013 -
Efficacy of multimodal, systematic non-surgical treatment of knee osteoarthritis for patients not eligible for a total knee replacement: a study protocol of a randomised controlled trial.
Skou ST, Roos EM, Laursen MB, Rathleff MS, et al · · 2012 · cited 16× · PMID 23151395 · DOI 10.1136/bmjopen-2012-002168 -
Cost-effectiveness of 12 weeks of supervised treatment compared to written advice in patients with knee osteoarthritis: a secondary analysis of the 2-year outcome from a randomized trial.
Skou ST, Roos EM, Laursen M, Arendt-Nielsen L, et al · · 2020 · cited 15× · PMID 32243994 · DOI 10.1016/j.joca.2020.03.009 -
Knee Confidence as It Relates to Self-reported and Objective Correlates of Knee Osteoarthritis: A Cross-sectional Study of 220 Patients.
Skou ST, Rasmussen S, Simonsen O, Roos EM. · · 2015 · cited 12× · PMID 26304646 · DOI 10.2519/jospt.2015.5864 -
Five-year follow-up of patients with knee osteoarthritis not eligible for total knee replacement: results from a randomised trial.
Larsen JB, Roos EM, Laursen M, Holden S, et al · · 2022 · cited 8× · PMID 36428014 · DOI 10.1136/bmjopen-2021-060169
Verify or expand the search:
- PubMed search for NCT01535001
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Osteoarthritis of the Knee
Currently open trials in the same condition.
- NCT07302204 — Efficacy of Aerobic Exercise Versus Therapeutic Exercises on Exercise-induced Hypoalgesia in Knee Osteoarthritis · NA · recruiting
- NCT06549686 — A Phase III Study of CLS2901C in Patients With Osteoarthritis of the Knee · Phase 3 · recruiting
- NCT05985785 — Bone Marrow Aspirate Concentrate (BMAC) vs Corticosteroid Injection · NA · recruiting
- NCT05035810 — A Pragmatic Trial to Determine the Benefit of Behaviorally Enhanced Exercise Incentives and Corticosteroid Injections in · Phase 3 · active not recruiting
- NCT04992624 — Cannabinoid Interactions With Central and Peripheral Pain Mechanisms in Osteoarthritis of the Knee · Phase 2 · recruiting
Other Northern Orthopaedic Division, Denmark trials
Trials by the same sponsor.
- NCT07202390 — Intraarticular Gold Microparticles for Knee Osteoarthritis · NA · not yet recruiting
- NCT05284253 — Is There an Allergy to Pure Metallic Gold Microparticles? · NA · unknown
- NCT06186115 — Intraarticular Gold Microparticles for Hip Osteoarthritis · unknown
- NCT04332055 — RCT Measuring the Effect of the ERVIN Software · NA · completed
- NCT02405104 — Chlorzoxazone in Hip and Knee Arthroplasty · Phase 4 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT01535001 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Northern Orthopaedic Division, Denmark
- Last refreshed: 14 September 2017
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01535001.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing